
Read More
India Markets Flat As Trump Threatens 200% Tariff on Pharma Imports...
The Nifty 50 declined 0.03 per cent to 25,514.6 while the BSE Sensex slipped 0.1 per cent to 83,625....

The Nifty 50 declined 0.03 per cent to 25,514.6 while the BSE Sensex slipped 0.1 per cent to 83,625....

Unichem Laboratories' decision to sell its Mumbai property boosts investor confidence as stock hits ...

With GLP-1 therapies expected to be a significant revenue driver in the future, Biocon aims to stren...

Despite the sharp decline, the regulatory setback isn't as severe as it seems—the letter only raises...

Regulatory changes, such as the US Biosecure Act, may accelerate growth for CDMO businesses. However...

The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing F...

Company's Board Approves Marketing and Supply Agreement with Mylan Pharmaceuticals...

The stock gave multibagger returns of over 200 per cent from its 52-week low of Rs 58.20 per share....

The company’s shares have delivered a multibagger return of over 200 per cent in the past 1 year....

The stock gave multibagger returns of 1,460 per cent in 2 years, 2,300 per cent in 3 years and a who...